22 results
Long-term safety of long-acting risperidone microspheres
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 193s
-
- Article
-
- You have access
- Export citation
The impact of side effects — Patient, family and physician concerns
-
- Journal:
- European Psychiatry / Volume 13 / Issue S4 / 1998
- Published online by Cambridge University Press:
- 16 April 2020, p. 225s
-
- Article
-
- You have access
- Export citation
Why it is sometimes difficult to generalize results from RCT's to everyday clinical practice
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S12
-
- Article
-
- You have access
- Export citation
JW01.03 - Lessons from schizophrenia study: Eufest
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, pp. S6-S7
-
- Article
-
- You have access
- Export citation
Executive functions in schizophrenia
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 23s
-
- Article
-
- You have access
- Export citation
DE03.01 Should-second Generation Antipsychotics be Favored Over Traditional Neuroleptics in the Treatment of Patients With Schizophrenia?
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, pp. 292s-293s
-
- Article
-
- You have access
- Export citation
The first-episode of schizophrenia: a challenge for treatment
-
- Journal:
- European Psychiatry / Volume 17 / Issue S4 / August 2002
- Published online by Cambridge University Press:
- 16 April 2020, pp. 371s-375s
-
- Article
- Export citation
S32.03 New antipsychotics: The issue of side-effects
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 278s
-
- Article
-
- You have access
- Export citation
P0117 - Weight change on aripiprazole-clozapine combination in schizophrenic patients with weight gain and suboptimal response on clozapine: 16-week double-blind study
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, pp. S114-S115
-
- Article
-
- You have access
- Export citation
Are specific studies needed for negative symptoms in schizophrenia?
-
- Journal:
- European Psychiatry / Volume 13 / Issue S4 / 1998
- Published online by Cambridge University Press:
- 16 April 2020, p. 146s
-
- Article
-
- You have access
- Export citation
Large pragmatic long term clinical trials in schizophrenia
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S55
-
- Article
-
- You have access
- Export citation
Osteoporosis in young patients with schizophrenia
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, pp. 36s-37s
-
- Article
-
- You have access
- Export citation
Safety, tolerability and compliance in the use of antipsychotics
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 62s
-
- Article
-
- You have access
- Export citation
Toward the reintegration of psychiatry and medicine in patients with mental illness
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S93
-
- Article
-
- You have access
- Export citation
W01.03 Why is it important for Austria to establish an anti-stigma-programme on schizophrenia?
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 259s
-
- Article
-
- You have access
- Export citation
S13.01 The world psychiatric association's consensus statement on the usefulness and use of second generation antipsychotic medications
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 236s
-
- Article
-
- You have access
- Export citation
PS04.01 Pharmacological treatment of schizophrenia
-
- Journal:
- European Psychiatry / Volume 15 / Issue S2 / October 2000
- Published online by Cambridge University Press:
- 16 April 2020, p. 314s
-
- Article
-
- You have access
- Export citation
2967 – Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E1784
-
- Article
-
- You have access
- Export citation
2277 – A Placebo-controlled Study Of Efficacy And Safety Of Aripiprazole Once-monthly For Long-term Maintenance Treatment In Schizophrenia
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E1426
-
- Article
-
- You have access
- Export citation
EPA-0790 – All-cause Discontinuation and Safety of Aripiprazole Once-Monthly for the Treatment of Schizophrenia: A Pooled Analysis of two Double-Blind, Randomized, Controlled Trials
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation